201 related articles for article (PubMed ID: 10963125)
1. Telomerase activity in cancer as a diagnostic and therapeutic target.
Kyo S; Takakura M; Inoue M
Histol Histopathol; 2000 Jul; 15(3):813-24. PubMed ID: 10963125
[TBL] [Abstract][Full Text] [Related]
2. Telomeres, telomerase, and myc. An update.
Cerni C
Mutat Res; 2000 Jan; 462(1):31-47. PubMed ID: 10648922
[TBL] [Abstract][Full Text] [Related]
3. Telomeres, telomerase, and telomerase inhibition: clinical implications for cancer.
Ahmed A; Tollefsbol T
J Am Geriatr Soc; 2003 Jan; 51(1):116-22. PubMed ID: 12534855
[TBL] [Abstract][Full Text] [Related]
4. Role of human telomerase reverse transcriptase and telomeric-repeat binding factor proteins 1 and 2 in human hematopoietic cells.
Yamada K; Yajima T; Yagihashi A; Kobayashi D; Koyanagi Y; Asanuma K; Yamada M; Moriai R; Kameshima H; Watanabe N
Jpn J Cancer Res; 2000 Dec; 91(12):1278-84. PubMed ID: 11123427
[TBL] [Abstract][Full Text] [Related]
5. Telomerase activation, cellular immortalization and cancer.
Hahn WC; Meyerson M
Ann Med; 2001 Mar; 33(2):123-9. PubMed ID: 11327115
[TBL] [Abstract][Full Text] [Related]
6. Suppressor of Ty homolog-5, a novel tumor-specific human telomerase reverse transcriptase promoter-binding protein and activator in colon cancer cells.
Chen R; Zhu J; Dong Y; He C; Hu X
Oncotarget; 2015 Oct; 6(32):32841-55. PubMed ID: 26418880
[TBL] [Abstract][Full Text] [Related]
7. Analytical validation of telomerase activity for cancer early detection: TRAP/PCR-CE and hTERT mRNA quantification assay for high-throughput screening of tumor cells.
Jakupciak JP; Wang W; Barker PE; Srivastava S; Atha DH
J Mol Diagn; 2004 Aug; 6(3):157-65. PubMed ID: 15269291
[TBL] [Abstract][Full Text] [Related]
8. Telomerase activity and expression of human telomerase catalytic subunit gene in esophageal tissues.
Tominaga T; Kashimura H; Suzuki K; Nakahara A; Tanaka N; Noguchi M; Itabashi M; Ohkawa J
J Gastroenterol; 2002; 37(6):418-27. PubMed ID: 12108675
[TBL] [Abstract][Full Text] [Related]
9. [Telomerase, cell immortality and cancer].
Watanabe N
Hokkaido Igaku Zasshi; 2001 May; 76(3):127-32. PubMed ID: 11481865
[TBL] [Abstract][Full Text] [Related]
10. The significance of telomerase activation and cellular immortalization in human cancer.
Newbold RF
Mutagenesis; 2002 Nov; 17(6):539-50. PubMed ID: 12435851
[TBL] [Abstract][Full Text] [Related]
11. Expression of human telomerase subunits and correlation with telomerase activity in urothelial cancer.
Ito H; Kyo S; Kanaya T; Takakura M; Inoue M; Namiki M
Clin Cancer Res; 1998 Jul; 4(7):1603-8. PubMed ID: 9676833
[TBL] [Abstract][Full Text] [Related]
12. Telomerase: a potential therapeutic target for cancer.
Fletcher TM
Expert Opin Ther Targets; 2005 Jun; 9(3):457-69. PubMed ID: 15948667
[TBL] [Abstract][Full Text] [Related]
13. hTERT expression in sporadic renal cell carcinomas.
Paradis V; Bièche I; Dargère D; Bonvoust F; Ferlicot S; Olivi M; Lagha NB; Blanchet P; Benoît G; Vidaud M; Bedossa P
J Pathol; 2001 Sep; 195(2):209-17. PubMed ID: 11592100
[TBL] [Abstract][Full Text] [Related]
14. Telomerase activity and expression of telomerase genes in squamous dysplasia and squamous cell carcinoma of the esophagus.
Yu HP; Xu SQ; Lu WH; Li YY; Li F; Wang XL; Su YH
J Surg Oncol; 2004 May; 86(2):99-104. PubMed ID: 15112252
[TBL] [Abstract][Full Text] [Related]
15. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
[TBL] [Abstract][Full Text] [Related]
16. Telomerase reverse transcriptase and telomeric-repeat binding factor protein 1 as regulators of telomerase activity in pancreatic cancer cells.
Yajima T; Yagihashi A; Kameshima H; Kobayashi D; Hirata K; Watanabe N
Br J Cancer; 2001 Sep; 85(5):752-7. PubMed ID: 11531263
[TBL] [Abstract][Full Text] [Related]
17. Regulation of human telomerase activity: repression by normal chromosome 3 abolishes nuclear telomerase reverse transcriptase transcripts but does not affect c-Myc activity.
Ducrest AL; Amacker M; Mathieu YD; Cuthbert AP; Trott DA; Newbold RF; Nabholz M; Lingner J
Cancer Res; 2001 Oct; 61(20):7594-602. PubMed ID: 11606399
[TBL] [Abstract][Full Text] [Related]
18. Elevated telomerase activity, c-MYC-, and hTERT mRNA expression: association with tumour progression in malignant lipomatous tumours.
Schneider-Stock R; Boltze C; Jäger V; Epplen J; Landt O; Peters B; Rys J; Roessner A
J Pathol; 2003 Apr; 199(4):517-25. PubMed ID: 12635143
[TBL] [Abstract][Full Text] [Related]
19. [Inhibitory effect of antisense human telomerase reverse transcriptase(hTERT) on telomerase activity of human pulmonary giant cell carcinoma cell line(PLA-801D)].
Ma XB; Han WD; Hao HJ; Li Q; Xu ZM; Lu XC; Zhao YL
Ai Zheng; 2003 Sep; 22(9):932-7. PubMed ID: 12969524
[TBL] [Abstract][Full Text] [Related]
20. [Detection of telomerase activity by semi-quantitative and in situ assays and quantification of hTERT expression in bladder carcinomas].
Longchampt E; Lebret T; Molinie V; Bieche I; Botto H; Lidereau R
Prog Urol; 2003 Apr; 13(2):238-45. PubMed ID: 12765058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
